Valve disease associated with ergot alkaloid use: echocardiographic and pathologic correlations.
Redfield
M M
MM
Mayo Clinic, Rochester, Minnesota.
Nicholson
W J
WJ
Edwards
W D
WD
Tajik
A J
AJ
D000328:Adult; D004452:Echocardiography; D004876:Ergot Alkaloids / Q000009:adverse effects*; D004878:Ergotamine / Q000009:adverse effects; D005260:Female; D006349:Heart Valve Diseases / Q000139:chemically induced* / Q000000981:diagnostic imaging / Q000473:pathology; D006350:Heart Valve Prosthesis; D006801:Humans; D008297:Male; D008784:Methysergide / Q000009:adverse effects; D008875:Middle Aged; D008944:Mitral Valve Insufficiency / Q000139:chemically induced; D008946:Mitral Valve Stenosis / Q000139:chemically induced
D004876:Ergot Alkaloids; D004878:Ergotamine; D008784:Methysergide